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Abstract  
 
Current technological advances have been present in all aspects of human life, including technological advances 
in biotechnology. Biotechnology not only raises hope for science but also raises heated debates among scientists, 
especially between the European Union and the US. This debate arises because of differences in perspective 
between the EU and the US. The EU has stringent rules regarding the development efforts of genetically modified 
organisms (GMOs). At the same time, the US thinks that GMOs are part of agriculture, so there is no need for any 
special laws to regulate them. Various side effects also come hand in hand with the birth of GMOs. They are 
ranging from adverse effects on human health, the health of food products, and even environmental damage. The 
development of GMOs can damage the ecosystem of species that exist in the environment. Still, more complex 
problems arise due to GMOs like economic problems and monopolies.  
 
Keywords: The  GMOs, The EU, The US. 
12 
 
1. Introduction   
 
Genetically modified organisms (GMOs) are organisms that have been altered 
using genetic engineering techniques. The presence of GMO crops plays an essential role 
in national food security. The presence of GMO food products or plants is not always 
beneficial. Some cases show GMO products causing adverse changes for the 
environment. The flow of genes from transgenic cultures to wild species has driven 
increasingly large and invasive and causes extinction in wild species.  
Corporation promoted GMO crops to meet food consumption needs. The process 
of making GMOs can change the composition of the environment, and GMOs can become 
toxins. New genes can cause inflammation from those that increase the formation of 
existing toxins or that lead to the accumulation of new viruses. At present, the use of 
GMOs has expanded due to many advantages obtained in this product. GMOs undeniably 
has several advantages. 
GMOs can be resistant to pests, resistant to various diseases, the use of fewer 
pesticides, have an attractive appearance, have more nutrients when compared to the 
original product, and so forth. The corporation claimed that GMOs would help the 
government to overcome the food crisis.  
GMO products are very likely to affect human health and environmental issues. 
The results found that the use of GMOs can harm the environment and species. GMOs 
and other biotechnological applications have raised ecological and economic problems. 
 
2. Literature Review   
 
In giving food and feed product choices to consumers in the EU, it must contain 
0.9% official GMOs and need to be labeled so that they can be tracked. But if the product 
comes from an animal that is fed GMO, it doesn't need to be labeled. The EU policy on 
GMOs began in 1999.  
The US has also experienced modern agriculture since the mid-1990s with the 
introduction of GMOs. GMOs' creation combines DNA from other species in ways that 
are not the same as working with nature. The leading developer created a series of plants 
with genetic traits that made it resistant to glyphosate herbicides. Other types of GMO 
plants are also genetically converted into poisons for insects that eat plants. GMO 
soybeans and corn are the two most popular types of GMO crops grown by farmers. GMO 
crops are also widely used in the United States, dominating millions of hectares of US 
agricultural land and has also become popular in South America.  
There is also concern that the widespread use of glyphosate herbicides in 
glyphosate-tolerant transgenic plants leaves pesticide residues in food that can interfere 
with human health that ingests food made from these plants. Many countries also prohibit 
the planting of GMO crops and must have strict requirements and labeling. 
GMO regulations have created challenges for the EU's external environmental 
policy towards the US. The EU has strict rules on GMO policies. The EU also adopted 
standards for GMO approval, labeling, and planting, which have been developing since 
the 1990s. During the 1990s, various EU member states took GMO bans, but the EU also 
approved the planting of eighteen genetically modified varieties. Then in 1998, the EU 
decided to ban the commercial introduction of genetically modified new products and 
adopted regulations to label genetically modified foods and feeds and tracing GMOs at 
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all stages of their production and consumption chain in 2003 GMO policies have caused 
the transatlantic conflicts.  
This fundamental difference between the European Union and the United States 
is the principle of the "Precautionary Principle." This principle emphasizes caution in 
accepting the new technology needed for technologies, which in terms of scientific 
understanding are unclear, and no agreement has yet found on the dangers or threats 
arising from these technologies. The European Union holds the form of the precautionary 
principle in terms of the entry of GMO products, namely in the way of product labeling. 
The desire of the European Union to label every GMO product is rejected by the United 
States, leading to differences in principles and ultimately leading to a rejection of the 
entry of GMO products into the European Union. 
The United States considers that GMO products are the same agricultural products 
as other conventionally grown agrarian products. It is different from the European Union. 
In the United States, three departments deal with agricultural products. (1) The United 
States Department of Agriculture (USDA) is responsible for protecting and securing 
crops and agriculture in the United States. (2) Environmental Protection Agency (EPA) 
is responsible for regulating the use of pesticides in genetically modified organism 
products. (3) The Food and Drug Administration (FDA) is the department most 
responsible for making regulations of genetically modified organisms. The Food and 
Drug Administration (FDA) is the department most responsible for establishing rules 
from GMOs, which, according to FDA policy, GMO products, are not dangerous except 
for some instances, and no special provisions are needed. 
This conflict occurred because the EU affirmed GMO's policy on environmental 
protection and human health, and the US considered this as protectionism. The European 
Union sees that the entry of GMO products is a form of threat that will endanger not only 
the health of consumers but also the environment so GMO products in the European 
Union must be limited. As a form of applying the precautionary principle held by the 
European Union, the European Union wants to label GMO products because consumers 
are entitled to get information about the food they consume. The United States and the 
European Union have different views on this issue. America is a country that looks at 
technology more in terms of output produced, while the European Union looks at the 
process of the production.  
The United States also sees the implementation of the precautionary principle as 
an act of the European Union in reducing trade competition in agriculture in the European 
Union because the presence of GMOs from the United States will be a rival for local 
products in Europe. The creation of GMO products and then marketing them to various 
countries in the world poses a threat to local products in these destination countries. The 
entry of GMO products from the United States into the European Union will affect the 
value of local goods. Local goods tend to have a higher value than imported goods. Seeing 
from the existing economic principles, consumers will tend to choose goods with prices 
that are cheaper than goods that are more expensive but with almost the same quality or 
even the same. The EU feared that the GMOs would harm domestic farmers, which will 
indirectly turn off the European Union's local industry.  
From a political perspective, the increase in the number of US exports to the 
European Union will further strengthen the position of the United States as a world 
superpower or hegemon. Surveys show that many American consumers like mandatory 
labeling of foods made with genetically modified ingredients. But many companies are 
blocking mandatory labeling, and this is very expensive and confusing consumer choices. 
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In 2016, President Barack Obama signed a law that carries the requirements for GMO 
labeling.  
 
3. Results and Discussions  
 
GMOs raise the pros and cons because the product has succeeded in contributing 
food to countries that lack food. The creation of GMOs as one of the food security efforts 
created by the United States for the world is certainly not readily accepted in various 
countries in the world, especially for states that have quite strict regulations on the entry 
of imported products such as those in the European Union. As a country producing GMO 
products, the United States has a different perspective on product creation when compared 
to the European Union, which maintains high standards of health and environmental 
protection.  
 In 2006, the final report issued by the WTO Dispute Resolution Panel concluded 
that policies made by the European Community in the form of a moratorium violated the 
WTO Agreement on the Application of Sanitation and Phytosanitary because it had 
caused unnecessary delays in imports. However, this was not justified by the European 
Communities because the moratorium was a policy related to procedures, and the nature 
of the regulation was temporary. Besides, the application of the Precautionary Principle 
is not an SPS rule. It has nothing to do with the regulations and competencies of the WTO. 
Still, it is more appropriate if it is associated with the Cartagena Protocol, which is a rule 
on environmental protection in the field of Biodiversity. The decision of the WTO Panel 
caused much debate regarding the competence of trade regulations and their relationship 
to the Precautionary Principle relating to environmental protection. With such an 
approach, the WTO has not been able to reach decisions that are relevant to policies 
outside of WTO arrangements.  
In sum, this does not lead to significant practice changes. The European Union 
urges the inclusion of the precautionary principle in the Cartagena 2000 Protocol on 
Biosafety. Because the US is not part of the Convention on Biological Diversity, the US 
is not a full negotiating partner in the preparation of the Cartagena Protocol, which is 
under the auspices of the Convention. However, the US remains involved in negotiations 
to some extent by providing input through the Miami Group as GMO producers and 
exporters.  
The Cartagena Protocol deals with transgenic movement across borders and 
establishes approval procedures based on advanced information for GMO imports into a 
country (Keilbach 2009, 120). It is only applied to parties to the Protocol and does not 
include the US. Biotechnical innovation will continue in the future, offering new 
opportunities for agriculture. Although all countries have the same goal of protecting the 
health and environment, regulations regarding the use of GMOs are very different. In 
short, the very different domestic approaches and international positions of the EU and 
the US have led to conflict. 
 
4. GMO in Spain (Case Study) 
 
 Primary GM plants incorporate cotton, canola, corn, soy, and sugar beets whose 
qualities have changed to make them impervious to illness, bugs, or natural conditions, 
for example, dry spell. Starting in 2017, 24 nations over the world developed GMOs. In 
any case, just two countries in Europe have biotech crops spanning just 0.1 million 
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hectares, contrasted and 72.9 million in the USA. Without precedent for the historical 
backdrop of GMO reception in the EU, in 2017, only two nations planted hereditarily 
altered maize: Spain and Portugal. The slight decrease of GMO appropriation throughout 
the years in Europe is because of imperfect yield edges, and the EU-wide move to 
dispense with biotech fixings to maintain a strategic distance from to incorporate the 
expression "Contain GMOs" on the naming. 
 There is a legal system that has been set up by the European Union (EU) to 
guarantee all improvement of current biotechnology happens in safe conditions - 
including GMOs. It intends not just to ensure human and creature wellbeing, and the 
earth, yet additionally administers clear naming and recognizability of GMOs available. 
As a significant aspect of the system, GMO companies need to experience a necessary 
application process, where they solicitation to either develop or showcase nourishment or 
feed inside the EU.  
These applications are comprising of a dossier with test information and hazard 
evaluation, which at that point, experiences an intricate and formal dynamic procedure. 
There is a further order which gives part expresses the option to forbid or confine the 
development of the harvest in their region for reasons, for example, natural or rural 
approach goals, or land use. So regardless of the yield is affirming at the EU level, the 
individual nation has the veto option the development of GMOs.   
  As of now, there is only one GMO developed in Spain – MON810 maize 
otherwise called Bt corn. It has been hereditarily altered to battle crop misfortune because 
of bugs and is endorsed for use far and wide from Argentina to Australia, and the US to 
Japan. It was supported by the European Union (EU) in 1998 and 2018 there were 115,000 
hectares of MON810 in Spain, and the reception is constrained to zones where the 
objective vermin, European corn borer, unleashes devastation (Catalonia, Aragon, and 
Extremadura). Nonetheless, four locales in Spain have pronounced themselves sans 
GMO, which shows that help for GMOs isn't nationwide.   
 The EU imports generous measures of GM feed, for example, soybean and other 
vegetable proteins, to take care of its animals. It is original from nations where the 
development of GMOs is far-reaching, for example, Brazil, Argentina, and the USA. 
Nonetheless, the quantity of GM nourishments on racks in Europe is little. It has been a 
credit to worries over the wellbeing and natural dangers of GMOs, the accessibility of 
non-GM options, and the marking commitments of the legal system. The EU legal system 
orders GM is marking "on any GM nourishment and feed containing, comprising of, or 
delivered from a GMO, aside from if the nearness is beneath 0.9% of the 
nourishment/feed, or the fixing is unusual or unavoidable". The mark should express, 
"This item contains hereditarily changed living beings" or "This item contains 
[genetically adjusted name]." It is likewise essential that it's anything but a lawful 
necessity to mark a meat item where the creature may have benefited from a transgenic 
feed. Specialists have expressed that it would be difficult to implement that standard.   
 Common elements empowering the worldwide extension of GMOs incorporate 
overwhelming venture, fixed universal costs, and the growing job of transnational 
organizations. The GMO circumstance in Spain can't comprehend without first getting a 
handle on the EU's constitutional structure for their approval. Regardless of logical 
discoveries and expanding concerns and in incredible appear differently concerning 
France's position, Spain, as of now, has the most elevated reception pace of Bt maize in 
the EU since it was first presented in 1998. In 2012, more than 120 thousand hectares of 
Bt maize were develop — 19.5 percent more than the earlier year — speaking to 90 
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percent of GM crops in the EU. So for what reason donations that share a typical European 
lawful system, just as the comparative atmosphere and soil conditions, have oppositely 
contradicted sees on this issue? A study is direct for the European Commission in 2005 
of every three of Spain's driving Bt maize-developing territories. While results do report 
better returns, the examination shows factual importance in just a single area, and all Bt 
maize created was sold for feed fabricating.  
  In 1998, the Spanish government approved two assortments of Bt maize 176 
simply because, entrusting the biomonitoring procedure to similar organizations that had 
made those assortments. The difference in government in 2004, from conservative to 
progressively focus situated, made it feasible for the flights originating from traditional 
society to listen to, and a delegate from the ecological part concede in the National 
Commission on Biosafety.  
The improvement of GMO sustenances in Europe happened all the while as the 
hidden steps toward a mix of national sanitation structures towards the European Food 
Safety Authority (EFSA) were happening. It was politically aggressive because national 
bodies electorate were losing a part of their effect over the privately settled rule. For 
instance, Reinheitsgebot or Germany's blend flawlessness laws had practically ensured 
that anything set apart as the ale expected to have been making in Germany.  
Distraught dairy animal illness in the UK was the most unmistakable of these 
occasions. Simultaneously, the radioactive contamination of European fields after 
Chernobyl drove Europeans to be particularly hesitant of awful logical choices made 
somewhere else. The Flavr Savr was the first monetarily grew innately assembled food 
to be permitted a license for human usage. The US biotechnology industry flaunted its 
way into this enough delicate regulatory Environment with GMO crops that they intended 
to offer to European farmers. They requested that Europeans simply recognize the 
security assessments that had just been made by a trio of US regulatory workplaces – the 
FDA, USDA, and the Environmental Protection Agency (EPA). The Europeans don't 
have of it.  
At the same time, they, European scientists, were moving into GMOs. A canned 
and named GMO tomato had been successfully test-exhibited in the mid-1990s through 
a supportive comprehension between Sainsbury's, a critical UK essential food thing chain, 
and the University of Nottingham. The news talked about the US biotechnology industry's 
undertaking to oblige its way into European markets began to break, activists began 
campaigns against "Frankenfoods." Sainsbury's opponents started to advertise that their 
store brands were "without GMO," and Sainsbury dropped the assessment, saying, "our 
customers have shown to us evidence that they don't require innately changed fixings." 
Simultaneously, American fundamental food thing chains are overall not.  
The commanding procedure has taken by the FDA against claims about rBST 
likely could be a contributing part to a legacy of American stores enduring the prosperity 
of GMO things. Additionally, as FDA has slackened up its undertakings to police ensures 
about the alleged clinical points of interest of sustenances, the American food industry 
has enabled signs of to pull in customers by touting the drawing in nature of characteristic 
or "sans GMO" food sources. The putative favorable circumstances of either are up 'til 
now not saw by US managerial associations.  
It is intended to remain ready and firm more; the item neglected to address the 
issues of the US tomato industry. In any case, there is additionally ice-nucleating or 
"Frostban" microbes; StarLink corn; the Pusztzai occurrence; African dismissal of US 
food help – the rundown proceeds.  
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Simultaneously, contemporary activists, who have presumably never known 
about Biotechnology's Bitter Harvest, are presently assembling consistently on the 
disappointment communicated a fourth of a century before making a monetarily and 
politically dynamic "food development." It needs nothing to do with biotechnology or 
hereditarily built nourishments. The EU Council sees the threats of GMOs as riskless to 
human prosperity yet rather more to the earth, alluding to the dangers of characterizing 
exceptional zones and non-GM crops. Spread through vertical and even quality trades, 
ruinous ramifications for non-focused on animals, and effects are maybe coming about in 
light of changes in plant rehearses.  
The EU and the United States would profit by a productive discourse over marking 
approaches and harmonization. On the off chance that they proceed to differ and pick 
generally dissimilar systems, the effects on a universal rural exchange, just as on the 
biotechnology business, will be prompt and generous. Additionally, a continued with 
impasse around there finds a way to hinder the progression of new biotechnology things 
that offer necessary overall clinical preferences later on. Even though the WTO has not 
explicitly communicated how it would address a trade contradiction about naming as a 
non-obligation limit, such an inquiry would decidedly be extravagant for the two 
countries to the extent of resources and time.  
An increasingly practical methodology would be for the two to start an exchange 
about naming choices, including negative marking, to build up a standard comprehension 
of the expected worldwide advantages and expenses related to various and orchestrated 
approaches. Notwithstanding, such a conversation must continue with due 
acknowledgment of the social contrasts in mentalities toward food and its job in public 
life and personality, and a thankfulness for the intense energy with which American 
science and industry approach innovative change.  
Germany presented the objective of conjunction between GM, non-GM, and 
natural plantings in 2005, consistent with the normal market direction of Directive 
18/2001. Simultaneously, Germany changed the meaning of a GMO to ensure against 
ecological contamination through GM plants. From that point forward, the German Act 
has characterized a GMO not just as a life form whose hereditary material is adjusting in 
a manner that doesn't normally happen by mating or common recombination. It 
additionally one that has come presence through mating or common recombination 
between a GMO and a non-GM life form. As needs are, plants that were unintentionally 
reproducing through recombination with GMOs likewise fall under the limitations of the 
Genetic Engineering Act, for example, requiring a grant to be advertised or discharged. 
Decisions in German legal disputes dependent on this extended definition have prompted 
the devastation of many polluted plantings. 
The German government has proposed to see on a case-by-case base whether 
those novel breeding methods cause GMOs and must be labeled. Green party gene-
splicing spokesman Harald Ebner demanded more transparency. The EU rules on GMOs 
clearly define a GMO as a process- but not product-related. Consumers must have the 
choice, Ebner told European Biotechnology. He accused the government's legal proposal 
to support industry interests to hunt out a backdoor to bring GMOs to the table. Along 
with the latest Eurobarometer polls, currently, there isn't any marketplace for GM food in 
Europe. The proportion of Europeans hostile GM food is 58%.  
If not, they argue, there's no difference to so-called natural products, that's highly 
optimized breeds using conventional breeding techniques. Internationally, regulations 
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concerning methods like oligonucleotide-directed mutagenesis or gene knock-out be 
genome editing are heterogeneous.   
The investigation's fundamental decisions are: The utilization of the preparatory 
guideline isn't gotten ready for CETA and not got prepared for TTIP. In the EU, 
government officials pick the endorsement of hereditarily adjusted plants before they're 
at any point set available.  
In North America, the specialists, alone, are blameworthy for both of these means. 
State Secretary Flachsbarth positively excused worries over purchaser insurance. No 
settling for the status quo, kind of conditioning of GMO guideline, are acknowledged 
through TTIP. The European Parliament got an opportunity at official, clear, and EU-
wide standards for the endorsement of hereditarily altered plants. In the interim, most of 
the populace has communicated clear resistance to biotechnology.  
 
5. Conclusions and Recommendations  
 
Genetically Modified Organisms (GMOs) are a portion of the world's most 
disputable innovations. Transoceanic debates emerging in relative to the strict 
administrative contrasts amongst the two significant structures — those of the United 
States and the European Union — have influenced science, speculation, and seeding 
choices around the world. This critical contrast amongst the European Union and the 
United States is the guideline of the "Prudent Principle" held by the European Union. This 
rule underscores alert in tolerating the innovation required for advances, which, as far as 
logical comprehension is indistinct and no understanding, has yet to be found on the risks 
or dangers emerging from these advances. The type of the preparatory is a guideline by 
the European Union as far as the passage of GMO items, to be specific as an item marking. 
The craving of the European Union to mark each GMO item is dismissed by the United 
States, prompting contrasts in standards and at last prompting a dismissal of the section 
of GMO items into the European Union. 
Work is presently ongoing to form plant-determined vaccination applicants in 
potatoes and lettuce for Norwalk Infection, Enterotoxigenic Escherichia coli (ETEC), and 
hepatitis B infection (HBV). Scientists are also studying the form of different significant 
proteins in various plants. Generally, modified organisms already used to elevate 
transplant tissues and human transplant organs. Many peoples additionally worry about 
possible risks. 
Other than the specialized complexities of concluding to manage the development 
and utilization of GMOs, there are not kidding inquiries regarding control of the 
administrative procedure. The ongoing BSE involvement with the UK outlines how the 
administration of guidelines intended to ensure buyers, without much of a stretch, clash 
with the compulsion to secure the controlled business. This sort of 'administrative catch' 
is a typical event as contending intrigues fight for control of the administrative procedure.   
On account of GMOs, there is significant weight from the multinationals to 
streamline the administrative procedure. Then again, those asking a progressively mindful 
methodology may incorporate ecological activists as well as business agrarian interests 
that could lose from rivalry with the development or importation of GMOs. 
In rundown, the guideline of something as mind-boggling as GMOs should never 
be possible on a simple objective, specialized premise. The appraisal of hazard and the 
translation of information will consistently be influence by the estimations of the 
controllers and the political and financial weights applied to the administrative procedure. 
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Be that as it may, progress towards progressively proper guidelines of GMOs can be made 
with access to adequate specialized and natural information and regulatory strategies that 
are as straightforward as could reasonably be expected.  
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